Human Food Safety Implications of Variation in Food Animal Drug Metabolism
暂无分享,去创建一个
[1] R. Gehring,et al. Excretory, Secretory, and Tissue Residues after Label and Extra-label Administration of Flunixin Meglumine to Saline- or Lipopolysaccharide-Exposed Dairy Cows. , 2015, Journal of agricultural and food chemistry.
[2] G. Paulson,et al. Depletion kinetics of 14C-sulfamethazine [4-amino-N-(4, 6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] metabolism in swine. , 1986, Drug Metabolism And Disposition.
[3] S. Sundlof,et al. Food Animal Residue Avoidance Databank (FARAD): An Automated Pharmacologic Databank for Drug and Chemical Residue Avoidance. , 1986, Journal of food protection.
[4] S. A. Brown,et al. Ceftiofur hydrochloride: plasma and tissue distribution in swine following intramuscular administration at various doses. , 1996, Journal of veterinary pharmacology and therapeutics.
[5] R. Gehring,et al. A framework for meta-analysis of veterinary drug pharmacokinetic data using mixed effect modeling. , 2015, Journal of pharmaceutical sciences.
[6] Comparison of plasma pharmacokinetics and bioavailability of ceftiofur sodium and ceftiofur hydrochloride in pigs after a single intramuscular injection. , 1999, Journal of veterinary pharmacology and therapeutics.
[7] C. Maltecca,et al. Differential Gene Expression across Breed and Sex in Commercial Pigs Administered Fenbendazole and Flunixin Meglumine , 2015, PloS one.
[8] R. Gehring,et al. Estimation of residue depletion of cyadox and its marker residue in edible tissues of pigs using physiologically based pharmacokinetic modelling , 2015, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
[9] J. Riviere,et al. Tabulation of FARAD Comparative and Veterinary Pharmacokinetic Data , 2006 .
[10] G. Ziv,et al. Tissue Distribution and Residues of Antibiotics in Normal and Emergency - Slaughtered Dairy Cows After Intramammary Treatment. , 1978, Journal of Food Protection.
[11] P. Toutain,et al. Pharmacokinetic/pharmacodynamic approach to assess irrelevant plasma or urine drug concentrations in postcompetition samples for drug control in the horse. , 2010, Equine veterinary journal.
[12] J. Riviere,et al. Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues. , 2005, American journal of veterinary research.
[13] T. Vree,et al. Age and dosage dependency in the plasma disposition and the renal clearance of sulfamethazine and its N4-acetyl and hydroxy metabolites in calves and cows. , 1986, American journal of veterinary research.
[14] M. Jacob,et al. Pharmacokinetics of enrofloxacin and ceftiofur in plasma, interstitial fluid, and gastrointestinal tract of calves after subcutaneous injection, and bactericidal impacts on representative enteric bacteria. , 2016, Journal of veterinary pharmacology and therapeutics.
[15] J. Riviere,et al. Screening and Confirmatory Analyses of Flunixin in Tissues and Bodily Fluids after Intravenous or Intramuscular Administration to Cull Dairy Cows with or without Lipopolysaccharide Challenge. , 2016, Journal of agricultural and food chemistry.
[16] D. E. Nelson,et al. Pharmacokinetics of sulfamethazine in male, female and castrated male swine. , 1984, Journal of veterinary pharmacology and therapeutics.
[17] M. Sheffer,et al. CHARACTERIZATION AND APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS IN RISK ASSESSMENT , 2011 .
[18] K. Odensvik,et al. High-performance liquid chromatography method for determination of flunixin in bovine plasma and pharmacokinetics after single and repeated doses of the drug. , 1995, American journal of veterinary research.
[19] P. Nielsen,et al. Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. , 1997, Pharmacology & toxicology.
[20] Jim E Riviere,et al. Health concerns and management of select veterinary drug residues. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[21] B. K. Park,et al. Altered pharmacokinetics of enrofloxacin in experimental models of hepatic and renal impairment , 2009, Veterinary Research Communications.
[22] P. Chiap,et al. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. , 2010, Journal of veterinary pharmacology and therapeutics.
[23] Z. Zeng,et al. Use of a Monte Carlo analysis within a physiologically based pharmacokinetic model to predict doxycycline residue withdrawal time in edible tissues in swine , 2012, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
[24] C. Maltecca,et al. The effect of breed and sex on sulfamethazine, enrofloxacin, fenbendazole and flunixin meglumine pharmacokinetic parameters in swine. , 2014, Journal of veterinary pharmacology and therapeutics.
[25] X. Miao,et al. Pharmacokinetics of ampicillin and sulfadimidine in pigs infected experimentally with Streptococcus suum. , 1997, Journal of veterinary pharmacology and therapeutics.
[26] A. Dreisbach,et al. The effect of chronic renal failure on drug metabolism and transport , 2008, Expert opinion on drug metabolism & toxicology.
[27] S. A. Brown,et al. Comparison of plasma pharmacokinetics and bioequivalence of ceftiofur sodium in cattle after a single intramuscular or subcutaneous injection. , 2000, Journal of veterinary pharmacology and therapeutics.
[28] R. Gehring,et al. Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans. , 2015, Journal of pharmaceutical sciences.
[29] J. Peggins,et al. Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacin. , 2010, Research in veterinary science.
[30] R. Zaylskie,et al. Steady state kinetics of 14C-sulfamethazine [4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide] metabolism in swine. , 1986, Drug Metabolism And Disposition.
[31] D. Foster,et al. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves. , 2007, Journal of veterinary pharmacology and therapeutics.
[32] F. Aarestrup,et al. Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. , 2002, Journal of veterinary pharmacology and therapeutics.
[33] R. Gehring,et al. Impact of an experimental PRRSV and Streptococcus suis coinfection on the pharmacokinetics of ceftiofur hydrochloride after intramuscular injection in pigs. , 2015, Journal of veterinary pharmacology and therapeutics.
[34] J. Riviere,et al. Comparison of ELISA and LC-MS/MS for the measurement of flunixin plasma concentrations in beef cattle after intravenous and subcutaneous administration. , 2013, Journal of agricultural and food chemistry.
[35] G. Smith,et al. A physiologically based pharmacokinetic model linking plasma protein binding interactions with drug disposition. , 2009, Research in veterinary science.
[36] M. Rantala,et al. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. , 2002, Journal of veterinary pharmacology and therapeutics.
[37] J. D. Weber,et al. Comparative Depletion of Sulfamethazine in Bob Veal, Fancy Veal, and Replacement Calves. , 1990, Journal of food protection.
[38] A. Tantituvanont,et al. Pharmacokinetics of ceftiofur hydrochloride in pigs infected with porcine reproductive and respiratory syndrome virus. , 2008, The Journal of antimicrobial chemotherapy.
[39] J. Riviere,et al. Comparison of pharmacokinetics and milk elimination of flunixin in healthy cows and cows with mastitis. , 2015, Journal of the American Veterinary Medical Association.
[40] V. Rodighiero. Effects of Liver Disease on Pharmacokinetics , 1999, Clinical pharmacokinetics.
[41] S. A. Brown,et al. Effects of age on the pharmacokinetics of single dose ceftiofur sodium administered intramuscularly or intravenously to cattle. , 1996, Journal of veterinary pharmacology and therapeutics.
[42] J. Riviere,et al. Use of Probabilistic Modeling within a Physiologically Based Pharmacokinetic Model To Predict Sulfamethazine Residue Withdrawal Times in Edible Tissues in Swine , 2006, Antimicrobial Agents and Chemotherapy.
[43] R. Upton. Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling. , 2008, Journal of pharmacological and toxicological methods.
[44] R. Gehring,et al. Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment. , 2016, Journal of veterinary pharmacology and therapeutics.
[45] A. Blikslager,et al. Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs. , 2012, Journal of veterinary pharmacology and therapeutics.
[46] J. Riviere,et al. Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus) , 2014, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
[47] A. Craigmill. A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. , 2003, Journal of veterinary pharmacology and therapeutics.
[48] Anna K. Johnson,et al. Pharmacokinetics of flunixin meglumine in mature swine after intravenous, intramuscular and oral administration , 2013, BMC Veterinary Research.
[49] Y. Hwang,et al. Effects of acute hepatic and renal failure on pharmacokinetics of flunixin meglumine in rats. , 2011, Experimental animals.